awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57216049-3C36E51A-8F00-4677-A920-1B2DF49B33FC
Q57216049-3C36E51A-8F00-4677-A920-1B2DF49B33FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57216049-3C36E51A-8F00-4677-A920-1B2DF49B33FC
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors
P2860
Q57216049-3C36E51A-8F00-4677-A920-1B2DF49B33FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57216049-3C36E51A-8F00-4677-A920-1B2DF49B33FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
89490917e735674aedececb27183d9fc8bc461fb
P2860
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial